Peter Atadja - Dec 15, 2022 Form 3 Insider Report for Onconova Therapeutics, Inc. (ONTX)

Role
Director
Signature
/s/ Mark Guerin, Attorney-in-Fact
Stock symbol
ONTX
Transactions as of
Dec 15, 2022
Transactions value $
$0
Form type
3
Date filed
12/19/2022, 05:50 PM
Next filing
Aug 14, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 attached